logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Lymphoma

    FiltersReset Filters
    49 results

    • allopurinol

      (allopurinol)
      Par Pharmaceutical, Inc.
      Usage: Allopurinol tablets are indicated for managing gout symptoms, cancer therapy-related elevated uric acid levels in adults and children, and recurrent calcium oxalate calculi in adults with high uric acid excretion. It is not recommended for treating asymptomatic hyperuricemia.

    • allopurinol

      (allopurinol)
      Mylan Pharmaceuticals Inc.
      Usage: Allopurinol tablets are indicated for managing gout symptoms, preventing elevated uric acid levels in patients with leukemia, lymphoma, and solid tumors undergoing treatment, and treating recurrent calcium oxalate stones in patients with high uric acid excretion. It is not recommended for asymptomatic hyperuricemia.

    • allopurinol

      (Allopurinol)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Allopurinol Tablets are indicated for managing gout symptoms, treating cancer patients with elevated uric acid levels due to therapy, and for adults with recurrent calcium oxalate stones despite lifestyle changes. It is not recommended for asymptomatic hyperuricemia.

    • bleomycin

      (BLEOMYCIN)
      Hospira, Inc.
      Usage: Bleomycin for Injection is a palliative treatment indicated for various neoplasms, including squamous cell carcinoma (head and neck, cervix, vulva), lymphomas (Hodgkin's and non-Hodgkin's), testicular carcinoma (embryonal cell, choriocarcinoma), and for managing malignant pleural effusions as a sclerosing agent.

    • cyclophosphamide

      (Cyclophosphamide)
      NorthStar RxLLC
      Usage: Cyclophosphamide for injection is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric patients with minimal change nephrotic syndrome who do not respond to corticosteroids.

    • cyclophosphamide

      (cyclophosphamide)
      Baxter Healthcare Corporation
      Usage: Cyclophosphamide for Injection is indicated for treating various malignancies in adults and pediatric patients, including malignant lymphomas, multiple myeloma, leukemias, and specific cancers like breast and ovarian carcinoma. It's also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy fails.

    • cyclophosphamide

      (cyclophosphamide)
      Civica, Inc.
      Usage: Cyclophosphamide for Injection is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, adenocarcinoma of the ovary, retinoblastoma, and breast carcinoma. It is also used for pediatric patients with minimal change nephrotic syndrome unresponsive to corticosteroids.

    • cyclophosphamide

      (Cyclophosphamide)
      Amneal Pharmaceuticals LLC
      Usage: Cyclophosphamide for injection is indicated for treating various malignant diseases, including specific types of lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, and certain carcinomas. It is also used in pediatric patients with biopsy-proven minimal change nephrotic syndrome who do not respond to steroid therapy.

    • cyclophosphamide

      (cyclophosphamide)
      Bamboo US Bidco LCC
      Usage: Cyclophosphamide is indicated for treating various malignant diseases, including lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids. Safety in adults for this condition is not established.

    • cyclophosphamide

      (Cyclophosphamide for Injection)
      Slate Run Pharmaceuticals, LLC
      Usage: Cyclophosphamide for Injection is indicated for treating various malignancies, including malignant lymphomas, multiple myeloma, leukemias, and solid tumors like breast cancer and ovarian adenocarcinoma. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome unresponsive to corticosteroid therapy.